首页> 外文期刊>Physiological chemistry and physics and medical NMR >Variation of Substituents on Pirarubicin for Enhancing Response to Hepatocellular Carcinoma and Pattern Recognition Analysis to Determine Analogy to Parent Drug
【24h】

Variation of Substituents on Pirarubicin for Enhancing Response to Hepatocellular Carcinoma and Pattern Recognition Analysis to Determine Analogy to Parent Drug

机译:吡柔比星上取代基的变化以增强对肝细胞癌的反应和模式识别分析,以确定与母体药物的类比

获取原文
获取原文并翻译 | 示例
       

摘要

Hepatocellular carcinoma arises from hepatocytes, it is the most common primary malignant tumor of the liver and accounts for the majority of liver cancers. Pirarubicin is a compound analog to the antineoplastic anthracycline antibiotic doxorubicin. Thereby as an intercalator of DNA, pirarubicin has shown efficacy in reducing tumor activity of hepatocellular carcinoma. Utilizing in silico optimized similarity of structure search of data base and replacement by isosteres, a total of nine analogs to pirarubicin were generated. The molecular size of ring substituents (approximately a base pair) were preserved and isosteres chosen to preserve the weak electrostatic properties permitting DNA intercalation. Only a small range in molecular weight and volume was permitted in order to preserve intercalation activity. Standard deviations for polar surface area, number of heavy atoms, molecular weight, molecular volume, and number of oxygens and nitrogens, were only 3.98%, 1.76%, 16.5%, 2.51%, and 0 %, respectively, of the overall average for these properties. Variation of the target substituent resulted in insignificant changes in many properties; there was a striking variation in the lipophilic property Log P. Values of Log P ranged from 0.142 to 2.078 inclusive of pirarubicin and plays an important role in bioavailability. Hierarchical cluster analysis indicated that all analogs, except analog 6, were substantially similar to pirarubicin. A similar outcome was obtained from non-metric multidimensional scaling of descriptors. However de-trended correspondence analysis distinguished both analogs 6 and 5 from the remaining analogs and pirarubicin. Nonhierarchical K-means clustering analysis determined greater differentiation among the analogs and pirarubicin. Analysis of similarity (ANOSIM) affirmed all compounds to be highly similar which shows structural optimization was achieved.
机译:肝细胞癌起源于肝细胞,它是最常见的肝原发性恶性肿瘤,占肝癌的大多数。吡柔比星是抗肿瘤药蒽环类抗生素阿霉素的化合物类似物。因此,吡柔比星作为DNA的嵌入剂已显示出降低肝细胞癌的肿瘤活性的功效。利用计算机优化的数据库结构搜索相似性和被等位基因替代,在计算机上优化了吡柔比星的九种类似物。保留了环取代基(大约一个碱基对)的分子大小,并选择了等排体以保留弱的静电特性,从而允许DNA嵌入。为了保留插入活性,仅允许分子量和体积的小范围内。极性表面积,重原子数,分子量,分子体积以及氧和氮的数目的标准偏差分别仅占总平均值的3.98%,1.76%,16.5%,2.51%和0%。这些属性。目标取代基的变化导致许多性质的变化不明显。亲脂性Log P发生了显着变化。LogP的值在0.142至2.078之间(包括吡柔比星),在生物利用度中起重要作用。层次聚类分析表明,除类似物6外,所有类似物均与吡柔比星基本相似。从描述符的非度量多维缩放获得了类似的结果。然而,去趋势对应分析将类似物6和5与其余类似物和吡柔比星区分开。非分层K均值聚类分析确定了类似物和吡柔比星之间的更大差异。相似性分析(ANOSIM)确认所有化合物都高度相似,表明已实现结构优化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号